Cohort of Patients With Hepatocellular Carcinoma or Cholangiocarcinoma (CHC/CC)

Assistance Publique - Hôpitaux de Paris

Status: Enrolling

Conditions: Hepatocellular Carcinoma; Cholangiocarcinoma

Study type: Observational

Funder types: Other

Identifiers

NCT04340986

APHP190473

IDRCB 2019-A01679-48 (Other Identifier)

Details and patient eligibility

About

The main objective is to describe the evolution of patients treated for a primary malignant hepatobiliary tumor (hepatocellular carcinoma or cholangiocarcinoma) over the long course.

Full description

The collection of data from patients with CHC and cholangiocarcinomas who are cancers with poor prognosis is a major challenge to improve patients'care (diagnosis, prognosis); facilitate the search for new therapeutic targets and the follow-up of clinical studies; and develop personalized treatments.

Enrollment: 1,250 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

Inclusion Criteria :

• Age ≥ 18 years olds
• Medical care in Nephrology department since 2015

Cholangiocarcinoma:

• Histologically and cytologically documented cholangiocarcinoma, regardless of the stage of the disease

Hepatocellular carcinoma:

• Hepatocellular carcinoma at any stage of the disease, presenting the diagnostic criteria according to the diagnostic criteria of Barcelona : Tumor of more than 1 cm, developed on cirrhosis liver with arterial phase hyperenhancement and washout in the portal venous or delayed phases on CT and MRI
• Hepatocellular histologically documented

Exclusion criteria

• Lack of patient non-opposition

Trial design

1,250 participants in 2 patient groups

patients with Hepatocellular carcinoma

patients with Cholangiocarcinoma